secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2023-01-26T23:59:59+00:00
Accession:  0001193125-23-016231
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q2 revenue up 16% to $1.03B, EPS $1.53; CEO Farrell appointed Board Chair
--------------------------------------------------------------------------------

- Revenue $1,033.7M (+16% YoY, +20% constant currency); GAAP EPS $1.53, non-GAAP $1.66.
- Gross margin contracted 30 bps to 56.1%; non-GAAP gross margin 56.8%.
- Mick Farrell, current CEO, named Board Chair; founder Peter Farrell becomes Chair Emeritus.
- Quarterly dividend $0.44/share declared, payable March 16, record date Feb 9.
- Closed acquisition of MEDIFOX DAN in Germany, expanding out-of-hospital SaaS business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312523016231/0001193125-23-016231-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312523016231/d369496d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-016231

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer